Skip to main content
ImmuneCited

Arginine methylation in the epithelial-to-mesenchymal transition.

Jian Qin, Jian Xu
Review The FEBS journal 2022 8 atıf
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D34358413'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Çalışma Türü
Review
Popülasyon
None
Müdahale
Arginine methylation in the epithelial-to-mesenchymal transition. None
Karşılaştırıcı
None
Birincil Sonuç
None
Etki Yönü
Mixed
Yanlılık Riski
Unclear

Abstract

Epithelial cells acquire mesenchymal characteristics during embryonic development, wound healing, fibrosis, and in cancer in a processed termed epithelial-to-mesenchymal transition (EMT). Regulatory networks of EMT are controlled by post-transcriptional, translational, and post-translational mechanisms, in which arginine methylation is critically involved. Here, we review arginine methylation-dependent mechanisms that regulate EMT in the aspects of signaling, transcriptional, and splicing regulation.

Kısaca

Arginine methylation‐dependent mechanisms that regulate EMT in the aspects of signaling, transcriptional, and splicing regulation are reviewed.

Used In Evidence Reviews

Similar Papers